Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).
about
The role of CD95 and CD95 ligand in cancerRegulation of the metastatic cell phenotype by sialylated glycansIdentification of the Calmodulin-Binding Domains of Fas Death ReceptorPARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression.Data-driven modeling of SRC control on the mitochondrial pathway of apoptosis: implication for anticancer therapy optimization.Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.Ca2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-SrcIdentification of initial leads directed at the calmodulin-binding region on the Src-SH2 domain that exhibit anti-proliferation activity against pancreatic cancerStructural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells.Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancerCell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2.Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.DICE: A novel tumor surveillance mechanism-a new therapy for cancer?Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathway-mediated Killer ActivityCalmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.
P2860
Q26995847-4B1BF0C4-CEE9-49F3-9BA8-1E8455BBF5F8Q27027559-C2061652-B1AB-4FEF-B7FF-E66C575DE5CCQ28552166-FF3C9B9A-B6D0-4D6E-9069-65BBDE4297B1Q33731141-82A603DC-47AA-4F8C-BC9E-9A1EF44841FFQ34371234-53F027AA-5539-4327-BBCE-34E7F626250AQ34671696-F2C1F4E2-B154-4DB4-BFCD-6649490CC36DQ35058949-C703DCAB-2609-4476-B566-75A8D2DA2EE6Q35658526-582752B6-DC1B-4006-9214-BD4E44E1FC42Q35902399-A13DD10C-89AC-44FA-8BDB-3B0F32F67142Q37048442-7B76D32B-23BE-4089-B782-4ED243AF0677Q37315146-98979229-F82E-420F-A742-F545AC0B76C9Q37488533-8DA32B21-E610-43D5-BB15-E2A6359958E9Q38839654-5BB7FD6D-FD03-4D5E-9D3F-D50D1BEE570FQ39013916-38001501-3B94-405A-BACD-3B75E0820DCFQ39474971-83C52886-4314-46E3-8869-CEA0B4CC5847Q40464867-BBD143C7-09F2-4CE9-869C-DF4534965C10Q41990852-8383E28E-BAEC-4DA5-B7A6-4AE6DB8E91F1Q51042741-DDBDB508-FDD1-432B-B41B-714BC5483351Q52583854-F12BF99D-EA01-4190-BFE8-D343A065784D
P2860
Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Calmodulin mediates Fas-induce ...... signal-regulated kinase (ERK).
@en
Calmodulin mediates Fas-induce ...... llular signal-regulated kinase
@nl
type
label
Calmodulin mediates Fas-induce ...... signal-regulated kinase (ERK).
@en
Calmodulin mediates Fas-induce ...... llular signal-regulated kinase
@nl
prefLabel
Calmodulin mediates Fas-induce ...... signal-regulated kinase (ERK).
@en
Calmodulin mediates Fas-induce ...... llular signal-regulated kinase
@nl
P2093
P2860
P356
P1476
Calmodulin mediates Fas-induce ...... signal-regulated kinase (ERK).
@en
P2093
Jay M McDonald
Jianfeng Chen
Kaiyu Yuan
Yabing Chen
P2860
P304
24776-24784
P356
10.1074/JBC.M110.202804
P407
P577
2011-05-25T00:00:00Z